← Leaderboards
Ellen McRae Greytak
Parabon Nanolabs, Inc.
$2,738,975
Attributed
$2,738,975
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $917.3K · FY2015–24$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,738,975 · 2
By mechanism
R44$2,559,156 · 1
R43$179,819 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPersonsMachine LearningAmericanGenome AnalysisPredictive ModelingS Disease RiskS DiseaseSensitivity And SpecificityValidationLate Onset Alzheimer DiseaseLifeGeneticGenetic RiskAffectClinical TrialsEarly TreatmentEarly InterventionEffective TherapyEarly DiagnosisDisorder RiskDiscriminationData SetGenotype
Grant awards (5)
Novel whole-genome analysis methods for Alzheimer's risk prediction$648,343
R44 · FY2024 · AG · contact PI
Novel whole-genome analysis methods for Alzheimer's risk prediction$917,300
R44 · FY2023 · AG · contact PI
Novel whole-genome analysis methods for Alzheimer's risk prediction$414,285
R44 · FY2019 · AG · contact PI
Novel whole-genome analysis methods for Alzheimer's risk prediction$579,228
R44 · FY2018 · AG · contact PI
Novel whole-genome analysis methods for Alzheimer's risk prediction$179,819
R43 · FY2015 · AG · contact PI